A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients.
Li H, Liu J, Chen J, Wang H, Yang L, Chen F, Fan S, Wang J, Shao B, Yin D, Zeng M, Li M, Li J, Su F, Liu Q, Yao H, Su S, Song E.
Li H, et al. Among authors: su s, su f.
Nat Commun. 2018 Apr 24;9(1):1614. doi: 10.1038/s41467-018-03537-w.
Nat Commun. 2018.
PMID: 29691399
Free PMC article.